TOP Recorder

Acceleron to Host Pulmonary Arterial Hypertension Research and Development Deep Dive Event on November 16 …
Business Wire (press release)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced it will webcast a live …
Pulmonary Arterial Hypertension Treatment Market Analysis, Growth, Trends & Forecast 2018-2024, With an Expected …News Australia Today

all 9 news articles »

X